We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+21.28%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$2.3B
AUM Growth
+$384M
Cap. Flow
+$216M
Cap. Flow %
9.39%
Top 10 Hldgs %
49.4%
Holding
255
New
116
Increased
33
Reduced
43
Closed
21

Top Buys

Rank Stock Value
1
KSPI icon
Kaspi.kz JSC
KSPI
+$20M
2
MREO
Mereo BioPharma
MREO
+$19.3M
3
BDX icon
Becton Dickinson
BDX
+$17.1M
4
SUNC
SunocoCorp LLC
SUNC
+$11.8M
5
MOH icon
Molina Healthcare
MOH
+$8.88M

Top Sells

Rank Stock Value
1
WDC icon
Western Digital
WDC
+$29.7M
2
QURE icon
uniQure
QURE
+$26.4M
3
LLY icon
Eli Lilly
LLY
+$21.8M
4
BBIO icon
BridgeBio Pharma
BBIO
+$19.6M
5
SNDK
Sandisk
SNDK
+$16.4M

Sector Composition

Rank Sector Weight
1 Healthcare 21.71%
2 Financials 6.94%
3 Consumer Discretionary 6.7%
4 Industrials 3.7%
5 Technology 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QURE icon
51
uniQure
QURE
$3.03B
$9.21M 0.4%
384,950
-685,050
-64% -$26.4M
WAL icon
52
Western Alliance Bancorporation
WAL
$9.2B
$8.41M 0.37%
100,000
– –
PCSC
53
DELISTED
Perceptive Capital Solutions
PCSC
$8.35M 0.36%
640,894
+140,894
+28% +$1.64M
APLS
54
DELISTED
Apellis Pharmaceuticals
APLS
$8.29M 0.36%
330,000
+42,000
+15% +$985K
ZVRA icon
55
Zevra Therapeutics
ZVRA
$594M
$8.11M 0.35%
905,000
-70,000
-7% -$662K
SOLS
56
Solstice Advanced Materials
SOLS
$9.89B
$7.93M 0.34%
+163,146
New +$7.68M
ALDX icon
57
Aldeyra Therapeutics
ALDX
$92.3M
$7.93M 0.34%
1,530,000
+710,000
+87% +$3.65M
GPK icon
58
Graphic Packaging
GPK
$3.36B
$7.8M 0.34%
+517,678
New +$8.51M
ARKG icon
59
PUT
ARK Genomic Revolution ETF
ARKG
$1.64B
$7.24M 0.32%
+250,000
New +$7.5M
IVVD icon
60
Invivyd
IVVD
$163M
$7.16M 0.31%
2,900,000
-3,400,000
-54% -$7.07M
GSAT icon
61
Globalstar
GSAT
$10.8B
$7.14M 0.31%
117,000
-3,000
-3% -$166K
SDRL icon
62
Seadrill
SDRL
$2.66B
$6.92M 0.3%
200,000
– –
VTOL icon
63
Bristow Group
VTOL
$1.35B
$6.81M 0.3%
186,000
+10,700
+6% +$403K
LEN icon
64
Lennar Class A
LEN
$20.5B
$6.73M 0.29%
65,500
-13,500
-17% -$1.63M
XHR
65
Xenia Hotels & Resorts
XHR
$1.89B
$6.41M 0.28%
453,000
-192,000
-30% -$2.62M
VKTX icon
66
Viking Therapeutics
VKTX
$3.8B
$6.4M 0.28%
182,000
-58,000
-24% -$2.06M
MREO
67
Mereo BioPharma
MREO
$51.4M
$6.26M 0.27%
15,025,000
+10,150,000
+208% +$19.3M
AMZN icon
68
Amazon
AMZN
$2.99T
$6.12M 0.27%
26,500
– –
PAX icon
69
Patria Investments
PAX
$1.8B
$5.8M 0.25%
365,000
-15,000
-4% -$225K
CZR icon
70
Caesars Entertainment
CZR
$6.06B
$5.71M 0.25%
244,000
+54,000
+28% +$1.21M
SNDK
71
Sandisk
SNDK
$211B
$5.7M 0.25%
24,000
-82,000
-77% -$16.4M
PURR
72
Hyperliquid Strategies Inc
PURR
$1.37B
$5.66M 0.25%
+1,590,000
New +$5.51M
CACI icon
73
CACI
CACI
$11.3B
$5.59M 0.24%
10,500
– –
CRESY
74
Cresud
CRESY
$796M
$5.35M 0.23%
423,552
-20,952
-5% -$232K
ALEC icon
75
Alector
ALEC
$168M
$5.23M 0.23%
3,350,000
+2,350,000
+235% +$4.17M
1 2
3
4 5

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, 683 Capital Management held 255 positions worth $2.3B, up 20% from $1.91B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

683 Capital Management deployed $216M of net new capital in Q4 2025, opening 116 new positions and adding to 33 existing holdings. Its largest new stake was Kaspi.kz JSC: 265,000 shares worth $20.7M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Western Digital, an estimated $29.7M trimmed.

  • 683 Capital Management's largest Q4 2025 buy was Kaspi.kz JSC: 265,000 shares worth $20.7M.
  • 683 Capital Management added most to Mereo BioPharma in Q4 2025, an estimated $19.3M increase.
  • 683 Capital Management's biggest Q4 2025 reduction was Western Digital, cutting an estimated $29.7M.
  • 683 Capital Management fully exited Eli Lilly in Q4 2025, selling an estimated $21.8M.
  • 683 Capital Management's ten largest holdings make up 49% of its $2.3B portfolio in Q4 2025.
  • 683 Capital Management opened 116 new positions and closed 21 in Q4 2025.
  • 683 Capital Management's portfolio value rose 20% quarter-over-quarter to $2.3B.

Based on 683 Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.